Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1595 studies found for:    "Alzheimer disease familial"
Show Display Options
RSS Create an RSS feed from your search for:
"Alzheimer disease familial"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Unknown  Alzheimer`s Disease Acitretin Medication
Condition: Alzheimer Disease
Interventions: Drug: Acitretin;   Drug: Placebo
2 Recruiting Alzheimer's Disease, Art and Garden
Condition: Alzheimer Disease
Intervention: Behavioral: Cognitive and psycho-behavioral effects of an artistic dimension
3 Completed Antigonadotropin-Leuprolide in Alzheimer's Disease Drug INvestigation (ALADDIN) VP 104 Study
Condition: Alzheimer Disease
Intervention: Drug: Leuprolide acetate
4 Terminated Early Markers of Alzheimer's Disease: Structural and Functional Brain Changes
Condition: Alzheimer's Disease
Intervention:
5 Completed Efficacy and Safety of LY451395 in Patients With Probable Alzheimer's Disease
Condition: Alzheimer's Disease
Intervention: Drug: LY451395
6 Unknown  Evaluation of 3APS in Patients With Mild to Moderate Alzheimer’s Disease
Condition: Alzheimer Disease
Intervention: Drug: 3APS
7 Completed Alzheimer's Disease Anti-Inflammatory Prevention Trial (ADAPT)
Condition: Alzheimer Disease
Interventions: Drug: Naproxen Sodium (Aleve);   Drug: Celecoxib (Celebrex)
8 Completed Gray Matters Alzheimer's Disease Prevention Intervention
Condition: Alzheimer's Disease
Intervention: Behavioral: Health education program
9 Completed Safety Study of PPI-1019 in Subjects With Mild-Moderate Alzheimer’s Disease
Condition: Alzheimer's Disease
Intervention: Drug: PPI-1019 (APAN)
10 Completed
Has Results
Effects of LY450139, on the Progression of Alzheimer's Disease as Compared With Placebo
Condition: Alzheimer's Disease
Interventions: Drug: LY450139;   Drug: Placebo
11 Completed
Has Results
Safety and Efficacy of Donepezil HCl 23 mg in Patients With Moderate to Severe Alzheimer's Disease
Condition: Alzheimer's Disease
Intervention: Drug: Donepezil HCL
12 Completed European Study of HF0220 in Mild to Moderate Alzheimer's Disease Patients
Condition: Alzheimer's Disease
Intervention: Drug: HF0220
13 Terminated
Has Results
Efficacy and Safety of Memantine in Moderate to Severe Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Drug: Memantine;   Drug: Placebo
14 Recruiting The Safety and Efficacy of Long-term Treatment of PINS Stimulator System for Patients With Alzheimer's Disease
Condition: Alzheimer's Disease
Intervention: Device: Deep Brain Stimulation (Beijing PINS Medical Co., Ltd)
15 Terminated Alzheimer Disease : Rehabilitation's Intervention at Home
Condition: Alzheimer's Disease
Intervention: Behavioral: Home rehabilitation therapy
16 Completed A Phase 2a Study to Evaluate the Effect of Rilapladib (SB-659032) in Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Drug: 250mg rilapladib;   Drug: placebo
17 Terminated Brain Imaging Study in Subjects With Alzheimer Disease in Comparison to Healthy Subjects
Condition: Alzheimer's Disease
Interventions: Drug: I-123-MNI-168;   Drug: 123-I MNI-168
18 Terminated
Has Results
Safety and Tolerability of Memantine in Moderate to Severe Alzheimer's Disease
Condition: Alzheimer's Disease
Intervention: Drug: Memantine
19 Withdrawn Cerebrolysin Compared to Donepezil in Patients With Mild to Moderate Dementia of Alzheimer's Type (DAT)
Condition: Alzheimer Disease
Interventions: Drug: Cerebrolysin;   Drug: Donepezil
20 Recruiting A Plan on Investigation and Collection of Aricept Safety Information With a Dose Increase on Alzheimer's Disease Patients
Condition: Alzheimer's Disease
Intervention: Drug: Aricept

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.